# NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

> **NCT05382377** · EARLY_PHASE1 · UNKNOWN · sponsor: **jianming xu** · enrollment: 18 (estimated)

## Conditions studied

- CRC
- Solid Tumor

## Interventions

- **BIOLOGICAL:** KD-025

## Key facts

- **NCT ID:** NCT05382377
- **Lead sponsor:** jianming xu
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-17
- **Primary completion:** 2024-05-17
- **Final completion:** 2026-05-17
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2022-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05382377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05382377, "NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05382377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*